Your browser doesn't support javascript.
loading
Predicting Microenvironment in CXCR4- and FAP-Positive Solid Tumors-A Pan-Cancer Machine Learning Workflow for Theranostic Target Structures.
Marquardt, André; Hartrampf, Philipp; Kollmannsberger, Philip; Solimando, Antonio G; Meierjohann, Svenja; Kübler, Hubert; Bargou, Ralf; Schilling, Bastian; Serfling, Sebastian E; Buck, Andreas; Werner, Rudolf A; Lapa, Constantin; Krebs, Markus.
Afiliação
  • Marquardt A; Department of Pathology, Klinikum Stuttgart, 70174 Stuttgart, Germany.
  • Hartrampf P; Department of Nuclear Medicine, University Hospital Würzburg, 97080 Würzburg, Germany.
  • Kollmannsberger P; Center for Computational and Theoretical Biology, University of Würzburg, 97074 Würzburg, Germany.
  • Solimando AG; Guido Baccelli Unit of Internal Medicine, Department of Precision and Regenerative Medicine and Ionian Area-(DiMePRe-J), School of Medicine, Aldo Moro University of Bari, 70124 Bari, Italy.
  • Meierjohann S; IRCCS Istituto Tumori "Giovanni Paolo II" of Bari, 70124 Bari, Italy.
  • Kübler H; Institute of Pathology, University of Würzburg, 97080 Würzburg, Germany.
  • Bargou R; Department of Urology and Pediatric Urology, University Hospital Würzburg, 97080 Würzburg, Germany.
  • Schilling B; Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, 97080 Würzburg, Germany.
  • Serfling SE; Department of Dermatology, University Hospital of Würzburg, 97080 Würzburg, Germany.
  • Buck A; Department of Nuclear Medicine, University Hospital Würzburg, 97080 Würzburg, Germany.
  • Werner RA; Department of Nuclear Medicine, University Hospital Würzburg, 97080 Würzburg, Germany.
  • Lapa C; Department of Nuclear Medicine, University Hospital Würzburg, 97080 Würzburg, Germany.
  • Krebs M; The Russell H Morgan Department of Radiology and Radiological Science, Division of Nuclear Medicine and Molecular Imaging, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.
Cancers (Basel) ; 15(2)2023 Jan 06.
Article em En | MEDLINE | ID: mdl-36672341
ABSTRACT
(1)

Background:

C-X-C Motif Chemokine Receptor 4 (CXCR4) and Fibroblast Activation Protein Alpha (FAP) are promising theranostic targets. However, it is unclear whether CXCR4 and FAP positivity mark distinct microenvironments, especially in solid tumors. (2)

Methods:

Using Random Forest (RF) analysis, we searched for entity-independent mRNA and microRNA signatures related to CXCR4 and FAP overexpression in our pan-cancer cohort from The Cancer Genome Atlas (TCGA) database-representing n = 9242 specimens from 29 tumor entities. CXCR4- and FAP-positive samples were assessed via StringDB cluster analysis, EnrichR, Metascape, and Gene Set Enrichment Analysis (GSEA). Findings were validated via correlation analyses in n = 1541 tumor samples. TIMER2.0 analyzed the association of CXCR4 / FAP expression and infiltration levels of immune-related cells. (3)

Results:

We identified entity-independent CXCR4 and FAP gene signatures representative for the majority of solid cancers. While CXCR4 positivity marked an immune-related microenvironment, FAP overexpression highlighted an angiogenesis-associated niche. TIMER2.0 analysis confirmed characteristic infiltration levels of CD8+ cells for CXCR4-positive tumors and endothelial cells for FAP-positive tumors. (4)

Conclusions:

CXCR4- and FAP-directed PET imaging could provide a non-invasive decision aid for entity-agnostic treatment of microenvironment in solid malignancies. Moreover, this machine learning workflow can easily be transferred towards other theranostic targets.
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha